These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1229807)

  • 21. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Horm Metab Res; 1982 May; 14(5):227-32. PubMed ID: 7047344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunogenicity of new insulins.
    Deckert T
    Diabetes; 1985 Jun; 34 Suppl 2():94-6. PubMed ID: 3888748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Considerations on the insulin-binding property of the blood of normal subjects and diabetics never treated with insulin].
    Lunetta M; Calcagno G; Motta L; Lombardo T
    Acta Diabetol Lat; 1968; 5(2):201-14. PubMed ID: 5724365
    [No Abstract]   [Full Text] [Related]  

  • 25. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
    Asplin CM; Hartog M; Goldie DJ
    Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of the insulin antibody titre in severe form of diabetes mellitus].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular size of insulin-anti-insulin immune complexes in the serum of diabetic patients].
    Brizzio AM; Nieto RR; Cedola N; Poskus E; Gagliardino JJ
    Medicina (B Aires); 1988; 48(2):113-9. PubMed ID: 3068475
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of circulating immune complexes in the pathogenesis of diabetes mellitus.
    Kilpatrick JM; Virella G
    Acta Diabetol Lat; 1982; 19(2):107-39. PubMed ID: 7051711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics.
    Gennaro WD; Van Norman JD
    Clin Chem; 1975 Jun; 21(7):873-9. PubMed ID: 236845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
    Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD
    Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for the immunoassay of insulin in the presence of insulin therapy-induced antibody.
    Davidson P; Deal RB
    J Lab Clin Med; 1976 Jun; 87(6):1050-6. PubMed ID: 778312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple method for the determination of serum free insulin levels in insulin-treated patients.
    Nakagawa S; Nakayama H; Sasaki T; Yoshino K; Yu YY
    Diabetes; 1973 Aug; 22(8):590-600. PubMed ID: 4579520
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin antibodies in aetiology of labile diabetes.
    Dixon K; Exon PD; Hughes HR
    Lancet; 1972 Feb; 1(7746):343-7. PubMed ID: 4109736
    [No Abstract]   [Full Text] [Related]  

  • 36. [Circulating immune complexes and insulin-binding capacity of the serum of diabetics].
    Vel'bri SK; Lilleorg AL; Kerge IaKh
    Probl Endokrinol (Mosk); 1986; 32(2):25-8. PubMed ID: 3520540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic insulin resistance.
    Davidson JK; DeBra DW
    Diabetes; 1978 Mar; 27(3):307-18. PubMed ID: 640236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
    Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
    Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.
    Roy B; Chou MC; Field JB
    J Clin Endocrinol Metab; 1980 Mar; 50(3):475-9. PubMed ID: 6987253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.